SBC MEDICAL GROUP HOLDINGS INCRPRTD C/WTS 17/09/2029 (TO PUR COM) | 8-K: FY2025 Q2 Revenue: USD 43.36 M

Revenue: As of FY2025 Q2, the actual value is USD 43.36 M.

EPS: As of FY2025 Q2, the actual value is USD 0.02.

EBIT: As of FY2025 Q2, the actual value is USD 15.19 M.

Segment Revenue

• Total revenues for the second quarter of 2025 were $43 million, an 18% decrease year-over-year.
• Total revenues for the first half of 2025 were $91 million, a 16% decrease year-over-year.

Operational Metrics

• Income from operations for the second quarter was $15 million, a 47% decrease year-over-year.
• Net income attributable to SBC Medical Group for the second quarter was $2.5 million, an 87% decrease year-over-year.
• EBITDA for the second quarter was $15 million, a 46% decrease year-over-year, with an EBITDA margin of 35% compared to 53% in the second quarter of 2024.
• Income from operations for the first half was $39 million, a 25% decrease year-over-year.
• Net income attributable to SBC Medical Group for the first half was $24 million, a 36% decrease year-over-year.
• EBITDA for the first half was $40 million, a 25% decrease year-over-year, with an EBITDA margin of 44% compared to 50% in the first half of 2024.

Cash Flow

• Net cash used in operating activities for the first half of 2025 was - $6,411,168, compared to $22,874,760 provided in the same period of 2024.
• Net cash provided by investing activities for the first half of 2025 was $15,397,998, compared to - $9,405,716 used in the same period of 2024.
• Net cash provided by financing activities for the first half of 2025 was $6,901,719, compared to - $109,341 used in the same period of 2024.

Unique Metrics

• The number of franchise locations increased to 259 as of June 30, 2025, up by 36 locations from June 30, 2024.
• The number of customers in the last twelve months ended June 30, 2025, was 6.31 million, a 14% increase year-over-year.
• The repeat rate for customers who visited franchisee’s clinics twice or more was 72%.

Outlook / Guidance

• SBC Medical is executing strategic shifts aimed at long-term competitiveness and scalability, including the discontinuation of the staffing business and targeted divestitures.
• The company is focused on optimizing its franchise model, capturing growth opportunities, transitioning to higher-margin models, and delivering lasting value to shareholders.
• Despite challenges in Japan’s consumer discretionary market, SBC Medical is advancing key initiatives, including the acquisition of MB career lounge and the integration of JUN CLINIC into its network.